| Markus Riester | and Medical Oncology Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute Department of Biostatistics, Harvard School of Public Health Department of Pathology Translational Medicine Division, Brigham and Women's Hospital, Boston Broad Institute of Harvard and MIT, Massachusetts Sidney Kimmel Cancer Center Department of Pathology, Johns Hopkins University, Memorial Sloan-Kettering Cancer Center, New York and Hospital del Mar Research Institute-IMIM, Barcelona and Hospital Parc Tauli |
| Markus Riester | and Medical Oncology Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute Department of Biostatistics, Harvard School of Public Health Department of Pathology Translational Medicine Division, Brigham and Women's Hospital, Boston Broad Institute of Harvard and MIT, Massachusetts Sidney Kimmel Cancer Center Department of Pathology, Johns Hopkins University, Memorial Sloan-Kettering Cancer Center, New York and Hospital del Mar Research Institute-IMIM, Barcelona and Hospital Parc Tauli |